Cargando…
Facial palsy as a manifestation of COVID‐19: A systematic review of cases
BACKGROUND AND AIMS: Facial palsy is a rare complication of the COVID‐19 infection. Herein, we conducted a systematic review of all published cases of facial palsy post‐COVID‐19 infection in an attempt to educate the general population and medical practitioners regarding the likely occurrence of fac...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9616168/ https://www.ncbi.nlm.nih.gov/pubmed/36320650 http://dx.doi.org/10.1002/hsr2.887 |
_version_ | 1784820592264871936 |
---|---|
author | Khurshid, Aiman Khurshid, Maman Sohail, Aruba Raza, Imran Mansoor Ahsan, Muhammad Khubab Alam Shah, Mir Umer Farooq Taseer, Anab Rehan Nashwan, Abdulqadir J. Ullah, Irfan |
author_facet | Khurshid, Aiman Khurshid, Maman Sohail, Aruba Raza, Imran Mansoor Ahsan, Muhammad Khubab Alam Shah, Mir Umer Farooq Taseer, Anab Rehan Nashwan, Abdulqadir J. Ullah, Irfan |
author_sort | Khurshid, Aiman |
collection | PubMed |
description | BACKGROUND AND AIMS: Facial palsy is a rare complication of the COVID‐19 infection. Herein, we conducted a systematic review of all published cases of facial palsy post‐COVID‐19 infection in an attempt to educate the general population and medical practitioners regarding the likely occurrence of facial palsy in COVID‐19 patients, its detection, effective treatment plan, and prognosis of the condition. METHODS: We searched PubMed, Google Scholar, and Directory of Open Access Journals (DOAJ) from December 1, 2019 to September 21, 2021. RESULTS: We included 49 studies bearing accounts of 75 cases who had facial palsy. The mean age of patients was 42.9 ± 19.59 years, with a male‐to‐female ratio of 8:7. The majority of the cases were reported from Brazil (n = 14), USA (n = 9), Turkey (n = 9), and Spain (n = 9). Noticeably, 30.14% of COVID‐19 patients were diagnosed with Guillain‐Barré syndrome. In total, 22.97% of patients complained of bilateral facial paralysis (n = 17), whereas ipsilateral paralysis was observed in 77.03% (n = 57). These were common complaints of Lagophthalmos, otalgia, facial drooping, dysarthria, and compromised forehead wrinkling. The treatment regimen mainly included the use of corticosteroids (n = 51) (69.86%), antivirals (n = 23) (31.51%), IVIG (n = 18) (24.66%), antibiotics (n = 13) (17.81%), antiretroviral (n = 9) (12.33%), and antimalarial (n = 8) (10.96%) medications. In all, 35.62% of patients (n = 26) adhered to a combination of antiviral and corticosteroid‐based therapy. Positive treatment outcomes were observed in 83.58% (n = 56) of cases. In contrast, 10 patients (14.93%) showed nonsignificant recovery, out of which 3 (4.48%) died from the disease. CONCLUSION: The association of facial palsy with COVID‐19 is controversial and therefore requires further investigation and published work to confirm a causal relationship. However, physicians should not overlook the likelihood of facial palsy post‐COVID‐19 infection and treat it accordingly. |
format | Online Article Text |
id | pubmed-9616168 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-96161682022-10-31 Facial palsy as a manifestation of COVID‐19: A systematic review of cases Khurshid, Aiman Khurshid, Maman Sohail, Aruba Raza, Imran Mansoor Ahsan, Muhammad Khubab Alam Shah, Mir Umer Farooq Taseer, Anab Rehan Nashwan, Abdulqadir J. Ullah, Irfan Health Sci Rep Narrative Review BACKGROUND AND AIMS: Facial palsy is a rare complication of the COVID‐19 infection. Herein, we conducted a systematic review of all published cases of facial palsy post‐COVID‐19 infection in an attempt to educate the general population and medical practitioners regarding the likely occurrence of facial palsy in COVID‐19 patients, its detection, effective treatment plan, and prognosis of the condition. METHODS: We searched PubMed, Google Scholar, and Directory of Open Access Journals (DOAJ) from December 1, 2019 to September 21, 2021. RESULTS: We included 49 studies bearing accounts of 75 cases who had facial palsy. The mean age of patients was 42.9 ± 19.59 years, with a male‐to‐female ratio of 8:7. The majority of the cases were reported from Brazil (n = 14), USA (n = 9), Turkey (n = 9), and Spain (n = 9). Noticeably, 30.14% of COVID‐19 patients were diagnosed with Guillain‐Barré syndrome. In total, 22.97% of patients complained of bilateral facial paralysis (n = 17), whereas ipsilateral paralysis was observed in 77.03% (n = 57). These were common complaints of Lagophthalmos, otalgia, facial drooping, dysarthria, and compromised forehead wrinkling. The treatment regimen mainly included the use of corticosteroids (n = 51) (69.86%), antivirals (n = 23) (31.51%), IVIG (n = 18) (24.66%), antibiotics (n = 13) (17.81%), antiretroviral (n = 9) (12.33%), and antimalarial (n = 8) (10.96%) medications. In all, 35.62% of patients (n = 26) adhered to a combination of antiviral and corticosteroid‐based therapy. Positive treatment outcomes were observed in 83.58% (n = 56) of cases. In contrast, 10 patients (14.93%) showed nonsignificant recovery, out of which 3 (4.48%) died from the disease. CONCLUSION: The association of facial palsy with COVID‐19 is controversial and therefore requires further investigation and published work to confirm a causal relationship. However, physicians should not overlook the likelihood of facial palsy post‐COVID‐19 infection and treat it accordingly. John Wiley and Sons Inc. 2022-10-28 /pmc/articles/PMC9616168/ /pubmed/36320650 http://dx.doi.org/10.1002/hsr2.887 Text en © 2022 The Authors. Health Science Reports published by Wiley Periodicals LLC. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Narrative Review Khurshid, Aiman Khurshid, Maman Sohail, Aruba Raza, Imran Mansoor Ahsan, Muhammad Khubab Alam Shah, Mir Umer Farooq Taseer, Anab Rehan Nashwan, Abdulqadir J. Ullah, Irfan Facial palsy as a manifestation of COVID‐19: A systematic review of cases |
title | Facial palsy as a manifestation of COVID‐19: A systematic review of cases |
title_full | Facial palsy as a manifestation of COVID‐19: A systematic review of cases |
title_fullStr | Facial palsy as a manifestation of COVID‐19: A systematic review of cases |
title_full_unstemmed | Facial palsy as a manifestation of COVID‐19: A systematic review of cases |
title_short | Facial palsy as a manifestation of COVID‐19: A systematic review of cases |
title_sort | facial palsy as a manifestation of covid‐19: a systematic review of cases |
topic | Narrative Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9616168/ https://www.ncbi.nlm.nih.gov/pubmed/36320650 http://dx.doi.org/10.1002/hsr2.887 |
work_keys_str_mv | AT khurshidaiman facialpalsyasamanifestationofcovid19asystematicreviewofcases AT khurshidmaman facialpalsyasamanifestationofcovid19asystematicreviewofcases AT sohailaruba facialpalsyasamanifestationofcovid19asystematicreviewofcases AT razaimranmansoor facialpalsyasamanifestationofcovid19asystematicreviewofcases AT ahsanmuhammadkhubab facialpalsyasamanifestationofcovid19asystematicreviewofcases AT alamshahmirumerfarooq facialpalsyasamanifestationofcovid19asystematicreviewofcases AT taseeranabrehan facialpalsyasamanifestationofcovid19asystematicreviewofcases AT nashwanabdulqadirj facialpalsyasamanifestationofcovid19asystematicreviewofcases AT ullahirfan facialpalsyasamanifestationofcovid19asystematicreviewofcases |